MTOR and breast cancer: Due to tumor-associated resistance to stress conditions, breast cancer cells can maintain high levels of cathepsin L. This aberrant cathepsin L activity in turn results in upregulation of the mammalian target of rapamycin (mTOR), a key regulator of tumor cell proliferation, tumor growth, survival, and angiogenesis [102].